GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » 3-Year FCF Growth Rate

Vitrolife AB (FRA:VTFN) 3-Year FCF Growth Rate : 15.00% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB 3-Year FCF Growth Rate?

Vitrolife AB's Free Cash Flow per Share for the three months ended in Mar. 2024 was €0.10.

During the past 12 months, Vitrolife AB's average Free Cash Flow per Share Growth Rate was 9.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 15.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 19.80% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Vitrolife AB was 138.10% per year. The lowest was -31.30% per year. And the median was 16.10% per year.


Competitive Comparison of Vitrolife AB's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Vitrolife AB's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's 3-Year FCF Growth Rate falls into.



Vitrolife AB 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Vitrolife AB  (FRA:VTFN) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Vitrolife AB 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (FRA:VTFN) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines